E-LIB Suche - Ergebnisse für: Wainberg, Z.A.

1

323P NALIRIFOX versus nab-paclitaxel and gemcitabine (Gem+N..:

Macarulla Mercade, T. ; Pazo Cid, R.A. ; Womack, M....
Annals of Oncology. 35 (2024) - p. S135-S136 , 2024

Link: https://doi.org/10.1016/..

2

504MO Phase I study of the PKMYT1 inhibitor lunresertib (lu..:

Wainberg, Z.A. ; Bent, A.H. ; Moreno, V....
Annals of Oncology. 35 (2024) - p. S201 , 2024

Link: https://doi.org/10.1016/..

3

128P A phase I dose escalation and expansion trial of LYT-2..:

Falchook, G. ; Rasco, D. ; Papadopoulos, K....
Immuno-Oncology and Technology. 20 (2023) - p. 100600 , 2023

Link: https://doi.org/10.1016/..

4

Claudin18.who? Examining biomarker overlap and outcomes in ..:

Klempner, S.J. ; Janjigian, Y.Y. ; Wainberg, Z.A.
ESMO Open. 8 (2023) 2 - p. 100778 , 2023

Link: https://doi.org/10.1016/..

5

Dabrafenib plus trametinib in patients with BRAF V600E-muta..:

Subbiah, V. ; Kreitman, R.J. ; Wainberg, Z.A....
Annals of Oncology. 33 (2022) 4 - p. 406-415 , 2022

Link: https://doi.org/10.1016/..

6

195TiP A first-in-human, phase I a/b dose escalation and ex..:

Csiki, I. ; Glenn, J. ; Boccia, R....
Immuno-Oncology and Technology. 16 (2022) - p. 100307 , 2022

Link: https://doi.org/10.1016/..

7

Biomarker analyses of second-line ramucirumab in patients w..:

Van Cutsem, E. ; Muro, K. ; Cunningham, D....
European Journal of Cancer. 127 (2020) - p. 150-157 , 2020

Link: https://doi.org/10.1016/..

8

3:00 PM Abstract No. 237 Additive benefit of yttrium-90 rad..:

HABER, Z. ; Lee, E. ; Price, M....
Journal of Vascular and Interventional Radiology. 31 (2020) 3 - p. S107 , 2020

Link: https://doi.org/10.1016/..

9

A phase II, randomised study of mFOLFOX6 with or without th..:

Bang, Y.-J. ; Kang, Y.-K. ; Ng, M....
European Journal of Cancer. 108 (2019) - p. 17-24 , 2019

Link: https://doi.org/10.1016/..

10

Cancer-Specific Mortality of Right- Versus Left-Sided Color..:

Wang, C. ; Wainberg, Z.A. ; Raldow, A..
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. E195-E196 , 2017

Link: https://doi.org/10.1016/..

11

Interim results from the phase I study of nivolumab (nivo) ..:

Wainberg, Z.A. ; George, B. ; Goldman, J.W....
European Journal of Cancer. 69 (2016) - p. S103 , 2016

Link: https://doi.org/10.1016/..

12

Circulating tumour cells as a biomarker for diagnosis and s..:

Ankeny, J S ; Court, C M ; Hou, S...
British Journal of Cancer. 114 (2016) 12 - p. 1367-1375 , 2016

Link: https://doi.org/10.1038/..

13

317 Safety and efficacy results from a phase 1 dose-escalat..:

Wainberg, Z.A. ; Hecht, J.R. ; Konecny, G.E....
European Journal of Cancer. 51 (2015) - p. S60 , 2015

Link: https://doi.org/10.1016/..

14

342 A Phase Ib/II study of alpelisib (BYL719) and ganitumab..:

Juric, D. ; Rodón, J. ; Bauer, T.M....
European Journal of Cancer. 51 (2015) - p. S68 , 2015

Link: https://doi.org/10.1016/..

15

11LBA Phase I study of the selective BRAFV600 inhibitor enc..:

Tabernero, J. ; van Geel, R. ; Bendell, J.C....
European Journal of Cancer. 50 (2014) - p. 199 , 2014

Link: https://doi.org/10.1016/..